1 January 2020 in American Journal of Ophthalmology
29 April 2022 in Journal of Ophthalmic and Vision Research
Purpose: To evaluate the ray tracing method's accuracy employing Okulix ray tracing software and thin-lens formulas to calculate intraocular lens (IOL) power using a swept-source optical coherence tomography (SS-OCT) biometer (OA2000). Methods: A total of 188 eyes from 180 patients were included in this study. An OA-2000 optical biometer was used to collect biometric data. The predicted postoperative refraction based on thin-lens formulas including SRK/T, Hoffer Q, Holladay 1, and Haigis formulas and the ray tracing method utilizing the OKULIX software was determined for each patient. To compare the accuracy of approaches, the prediction error and the absolute prediction error were determined. Results: The mean axial length (AL) was 23.66 mm (range: 19–35). In subgroup analysis based on AL, in all ranges of ALs the ray tracing method had the lowest mean absolute error (0.56), the lowest standard deviation (SD; 0.55), and the greatest proportion of patients within 1 diopter of predicted refraction (87.43%) and the lowest absolute prediction error compared to the other formulas (except to SRK/T) in the AL range between 22 and 24 mm (all P < 0.05). In addition, the OKULIX and Haigis formulas had the least variance (variability) in the prediction error in different ranges of AL. Conclusion: The ray tracing method had the lowest mean absolute error, the lowest standard deviation, and the greatest proportion of patients within 1 diopter of predicted refraction. So, the OKULIX software in combination with SS-OCT biometry (OA2000) performed on par with the third-generation and Haigis formulas, notwithstanding the potential for increased accuracy in the normal range and more consistent results in different ranges of AL.
6 July 2025 in Mycopathologia
1 April 2020 in Multiple Sclerosis and Related Disorders
18 September 2023 in Ophthalmic Plastic & Reconstructive Surgery
Purpose: To review the existing literature on patients with anaplastic large cell lymphoma (ALCL) affecting the globe and/or ocular adnexa, and to present a report documenting the clinical course of a patient with ALCL that involved their globe and ocular adnexa. Methods: PubMed, Scopus, and Google scholar were systematically searched for all cases of ALCL involving intraocular or adnexal ocular structures from inception to May 2023. Moreover, a new reported case added to the cases found in searches. Results: The review identified 1680 studies, with 8 meeting inclusion criteria. A total of 9 patients were included with a mean age of 29.7 years (median: 30.0, range: 1.3–48). Primary ALCL was present in 5/9 (55.6%) patients. The most common ophthalmic manifestations included periorbital swelling (5/8), chemosis (5.8), and decreased vision (5/7). Misdiagnoses were initially made in 3 patients, and the lag time to correct diagnosis from 3 weeks to 3 months. CD30 expression was positive in all cases, and 6/9 patients were positive for anaplastic lymphoma kinase, resulting in 6/9 patients being diagnosed with anaplastic lymphoma kinase-positive ALCL. In terms of management modalities, chemotherapy was administered in 8/9 patients, while radiation therapy was utilized in 4/9 patients, and 2 underwent autologous stem cell transplantation. Five (55.6%) patients succumbed to ALCL while 4 (44.4%) were alive and disease-free at the last follow-up. The median times from the initial presentation of ALCL to death, ophthalmic presentation to death, and diagnosis to death were 4.12 months (range: 1.1–168.0), 2.62 months (range: 1.1–144), and 4.00 months (range: 0.10–168), respectively. The median follow-up duration was 21.0 months (range: 1.1–168.0). Conclusions: ALCL involving the globe and ocular adnexa is a rare and highly malignant tumor that can mimic benign clinical conditions. Early biopsy and aggressive treatment with chemotherapy regimens such as CHOP and radiation therapy may be useful.